The Hukui Biotechnology Corporation in Collaboration with the Zhongguancun Medical Engineering Transformation (Chongqing) Center to Obtain a Category III License from the CFDA for Medical Equipment

The Hukui Biotechnology (Chongqing) Corporation, the subsidiary of Hukui Biotechnology Corporation, signed the Cooperation Framework Agreement with the Zhongguancun Medical Engineering Transformation (Chongqing) Center to promote the development of the biotechnology industry. The goal of the Agreement is to create a biotech incubator platform that promotes the smart medical industry focusing on the development of medicine, top-of-the-range medical equipment, testing reagents, and stem-cell technology. Under this collaboration, the Hukui Biotechnology (Chongqing) Corporation is responsible for screening and introducing excellent biotech companies and products to Chongqing. The Zhongguancun Medical Engineering Transformation (Chongqing) Center then helps these companies to establish themselves in Chongqing and apply for licenses. The main goal is to obtain a Category III license for medical equipment granted by the CFDA.

 Compal Group cooperate with Hukui Biotechnology Corporation to Enter Medical Market in China

Compal Group cooperate with Hukui Biotechnology Corporation to Enter Medical Market in China

Taipei, Taiwan, June 13, 2017 General Life Biotechnology Co., Ltd., an affiliate of Compal Group (TWSE:2324), has signed a contract with Hukui Biotechnology Corporation. General Life Biotechnology Co., Ltd. will provide the key components and technical support, and Hukui Technology, the Chongqing-based subsidiary of Hukui Biotechnology Corporation is then responsible to apply for the license…